How prevalent is testosterone deficiency? A GP’s guide to what men want - QI&CPD - Category 2

Duration

1.5 hrs

Profession

Physician

# of Credits

3.0

Accreditation

QI & CPD - Category 2

Expiry Date

2020-03-14

Male hypogonadism is a clinical syndrome that occurs due to disruption of the hypothalamic–pituitary–testicular (HPT) axis, and results in failure to produce physiological levels of testosterone and normal numbers of spermatozoa. It includes androgen deficiency and infertility, which may be present together or separately. Hypogonadism can be further divided into subtypes on the basis of the location of the dysfunction of the HPT axis:

  • Primary if the dysfunction is located at the level of the testes
  • Secondary if the dysfunction is located at the level of the hypothalamus or pituitary gland


This activity has been approved by The Royal Australian College of General Practitioners QI&CPD Program.Total Points: 3.00 Point(s) (Category 2)

Michael Lowy
(MBBS, MPM, FAChSHM, FECSM
Visiting Lecturer
UNSW, Sydney University
Notre Dame University & Family Planning NSW
Clinical Student Tutor
Prince of Wales Hospital, Randwick, NSW),

Professor Steven C. Boyages
(MB BS PhD FRACP FAFPHM DDU
Senior Endocrinologist, Westmead Hospital
Clinical Professor, The University of Sydney
Clinical Professor, the University of Western Sydney)

On completion of this program, participants will be better able to:

  1. Recognise the prevalence of hypogonadism, and the barriers men face when presenting to GPs
  2. Identify the symptoms and co-morbidities associated with testosterone deficiency, and recognise that these may occur at testosterone levels that are greater than those identified by the PBS for reimbursement
  3. Counsel patients on risks and benefits of testosterone replacement therapy
  4. Guide patients on how to select the most appropriate treatment option that can be tailored to achieve good patient outcomes


Related Courses